AKT1 and diabetes mellitus: To verify the mechanism of its cardioprotective effect, we applied the PI3K phosphorylation inhibitor wortmannin before treatment with I-Post combined with nicorandil in diabetic I/R rats, observed the extent of myocardial injury and analysed the expression of related protein phosphorylation in the PI3K/Akt signalling pathway.